Jan 13, 2014
Nov 28, 2013
KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
Aug 12, 2013
Jun 05, 2013
Jul 09, 2014
U.S. drugmaker AbbVie has been forced to retract comments by its chief executive about shareholder support for its $51 billion bid for Shire after being caught out by British takeover rules...
Jul 08, 2014
U.S. drugmaker AbbVie raised its offer for Shire to 51...
Jun 24, 2014
U.S. healthcare firm Abbott Laboratories is to buy Russian drugmaker Veropharm for up to $495 million, giving it a manufacturing presence in a country where it has been operating for nearly 40 years, Abbott said on Tuesday...